[
  {
    "ts": null,
    "headline": "What's going on in today's session: S&P500 movers",
    "summary": "Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.",
    "url": "https://finnhub.io/api/news?id=eaf2c0fa8d47c7038de750abd84a4ea4ca0a65939ad79483f08b3f1a92727c5a",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771436106,
      "headline": "What's going on in today's session: S&P500 movers",
      "id": 139137632,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "ABBV",
      "source": "ChartMill",
      "summary": "Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.",
      "url": "https://finnhub.io/api/news?id=eaf2c0fa8d47c7038de750abd84a4ea4ca0a65939ad79483f08b3f1a92727c5a"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For February",
    "summary": "IXJ: Healthcare Sector Dashboard For February",
    "url": "https://finnhub.io/api/news?id=4c7217c375ec3588b7d733d67e76ed36acfbee5d367368b6809a501d5b536ff7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771408800,
      "headline": "IXJ: Healthcare Sector Dashboard For February",
      "id": 139136343,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4c7217c375ec3588b7d733d67e76ed36acfbee5d367368b6809a501d5b536ff7"
    }
  },
  {
    "ts": null,
    "headline": "Piper Sandler Maintains Overweight on AbbVie, Raises Price Target to $299",
    "summary": "Piper Sandler  analyst David Amsellem   maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $289 to $299.",
    "url": "https://finnhub.io/api/news?id=81b3bba1cadb67cae73521aa21afeba169853852a92522b9daa690c2461d4f1d",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771403081,
      "headline": "Piper Sandler Maintains Overweight on AbbVie, Raises Price Target to $299",
      "id": 139133676,
      "image": "",
      "related": "ABBV",
      "source": "Benzinga",
      "summary": "Piper Sandler  analyst David Amsellem   maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $289 to $299.",
      "url": "https://finnhub.io/api/news?id=81b3bba1cadb67cae73521aa21afeba169853852a92522b9daa690c2461d4f1d"
    }
  },
  {
    "ts": null,
    "headline": "1 Mega-Cap Stock on Our Watchlist and 2 We Avoid",
    "summary": "Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works against them.",
    "url": "https://finnhub.io/api/news?id=2409aa7439d14b10ced1c94fbe3737ee10293a377cf1689f625fd5280554c47a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771389161,
      "headline": "1 Mega-Cap Stock on Our Watchlist and 2 We Avoid",
      "id": 139132613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works against them.",
      "url": "https://finnhub.io/api/news?id=2409aa7439d14b10ced1c94fbe3737ee10293a377cf1689f625fd5280554c47a"
    }
  }
]